Physician profile
John Rawa
NPI 1205802352
$683.01
in general payments reported to CMS, 2019-2025
8 companies · $422 in 2025
The $422 reported for 2025 was more than what 89% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.50 · 2020: $20.35 · 2023: $106 · 2024: $121 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330 · Gift: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.67 |
| Gift | $319.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $326.83 | 2025 | Opalescence |
| Align Technology, INC. | $197.74 | 2020-2025 | Invisalign, Itero Element 5d Plus, Invisalign Go |
| Dentsply Sirona INC | $68.03 | 2019-2025 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Surefil Sdr Flow+ Bulk Fill Flowable |
| Patterson Companies, INC. | $32.57 | 2025 | |
| Nobel Biocare USA | $16.48 | 2023 | Nobelactive |
| Kerr Corporation | $16.48 | 2023 | Harmonize |
| Colgate Oral Pharmaceuticals, INC. | $14.88 | 2025 | |
| Biolase, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.